ARTICLE | Financial News
EntreMed raises $26.1 million
February 27, 2001 8:00 AM UTC
ENMD, a developer of antiangiogenesis therapeutics for cancer, raised $26.1 million in a trimmed-down follow-on through the sale of 1.45 million shares at $18. The company originally filed on Feb. 5 t...